Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Functional and topological properties in hepatocellular carcinoma transcriptome.

Drozdov I, Bornschein J, Wex T, Valeyev NV, Tsoka S, Malfertheiner P.

PLoS One. 2012;7(4):e35510. doi: 10.1371/journal.pone.0035510. Epub 2012 Apr 23.

2.

Dynamic protein interaction modules in human hepatocellular carcinoma progression.

Yu H, Lin CC, Li YY, Zhao Z.

BMC Syst Biol. 2013;7 Suppl 5:S2. doi: 10.1186/1752-0509-7-S5-S2. Epub 2013 Dec 9.

3.

The HOX gene network in hepatocellular carcinoma.

Cillo C, Schiavo G, Cantile M, Bihl MP, Sorrentino P, Carafa V, D' Armiento M, Roncalli M, Sansano S, Vecchione R, Tornillo L, Mori L, De Libero G, Zucman-Rossi J, Terracciano L.

Int J Cancer. 2011 Dec 1;129(11):2577-87. doi: 10.1002/ijc.25941. Epub 2011 May 30.

4.

AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues.

Wang L, Huang J, Jiang M, Zheng X.

Tumour Biol. 2010 Oct;31(5):417-25. doi: 10.1007/s13277-010-0050-8. Epub 2010 Jun 8.

PMID:
20532728
5.

A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.

Schröder PC, Segura V, Riezu JI, Sangro B, Mato JM, Prieto J, Santamaría E, Corrales FJ.

Funct Integr Genomics. 2011 Sep;11(3):419-29. doi: 10.1007/s10142-011-0230-7. Epub 2011 May 12.

PMID:
21562899
6.

Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.

Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P, Fisher R.

Mol Med. 2009 Mar-Apr;15(3-4):85-94. doi: 10.2119/molmed.2008.00110. Epub 2008 Dec 15.

7.
8.

[Predication analysis of microarray data to determine altered gene profiles in liver carcinoma related to HBV-related cirrhosis].

Liu J, Zhang Q, Li Z, Zhang Q, Qu Y, Lu L, Xu M.

Zhonghua Gan Zang Bing Za Zhi. 2014 Aug;22(8):625-30. doi: 10.3760/cma.j.issn.1007-3418.2014.08.015. Chinese.

PMID:
25243966
9.

Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.

Ramesh V, Ganesan K.

Int J Cancer. 2016 Oct 1;139(7):1586-97. doi: 10.1002/ijc.30195. Epub 2016 Jun 6.

10.

Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma.

Zheng S, Tansey WP, Hiebert SW, Zhao Z.

BMC Med Genomics. 2011 Aug 8;4:62. doi: 10.1186/1755-8794-4-62.

11.

Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.

He B, Yin J, Gong S, Gu J, Xiao J, Shi W, Ding W, He Y.

Medicine (Baltimore). 2017 Jun;96(25):e6938. doi: 10.1097/MD.0000000000006938.

12.

Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.

Gehrau RC, Archer KJ, Mas VR, Maluf DG.

PLoS One. 2012;7(7):e40275. doi: 10.1371/journal.pone.0040275. Epub 2012 Jul 5.

13.

Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.

Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, Yamada T.

Clin Cancer Res. 2010 May 1;16(9):2518-28. doi: 10.1158/1078-0432.CCR-09-2214. Epub 2010 Apr 13.

14.

Selection of reference genes for RT-qPCR analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis B infection and cirrhosis.

Liu S, Zhu P, Zhang L, Ding S, Zheng S, Wang Y, Lu F.

Cancer Biomark. 2013;13(5):345-9. doi: 10.3233/CBM-130365.

PMID:
24440974
15.

Strong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysis.

Wang F, Chang Y, Li J, Wang H, Zhou R, Qi J, Liu J, Zhao Q.

Dig Liver Dis. 2017 Jan;49(1):70-76. doi: 10.1016/j.dld.2016.10.017. Epub 2016 Nov 4.

PMID:
27876500
16.

Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.

Wright JH, Johnson MM, Shimizu-Albergine M, Bauer RL, Hayes BJ, Surapisitchat J, Hudkins KL, Riehle KJ, Johnson SC, Yeh MM, Bammler TK, Beyer RP, Gilbertson DG, Alpers CE, Fausto N, Campbell JS.

Int J Cancer. 2014 Feb 15;134(4):778-88. doi: 10.1002/ijc.28421. Epub 2013 Sep 16.

17.

Bioinformatics analysis of gene expression profiles in hepatocellular carcinoma.

Shangguan H, Tan SY, Zhang JR.

Eur Rev Med Pharmacol Sci. 2015;19(11):2054-61.

18.

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.

Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, Liu F, Huang QH, Cheng ZH, Li NG, Du JJ, Hu W, Shen KT, Lu G, Fu G, Zhong M, Xu SH, Gu WY, Huang W, Zhao XT, Hu GX, Gu JR, Chen Z, Han ZG.

Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15089-94.

19.

Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.

Wang L, Huang J, Jiang M, Sun L.

J Cell Biochem. 2011 May;112(5):1286-94. doi: 10.1002/jcb.23030.

PMID:
21312234
20.

Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.

Lee S, Mardinoglu A, Zhang C, Lee D, Nielsen J.

Nucleic Acids Res. 2016 Jul 8;44(12):5529-39. doi: 10.1093/nar/gkw462. Epub 2016 May 23.

Supplemental Content

Support Center